Trial intelligence / Profile preview

Botox for Ankle Dorsiflexion After Pilon Fracture

NCT02051933Terminated

Sponsor
Wake Forest University Health Sciences
Start
Jan 2013
Primary completion
Mar 2016
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, double-blind trial in equinus contracture comparing Botox Arm with Placebo Arm (2 arms). Primary endpoint: Ankle Dorsiflexion of Injured Extremity at 6 months. Started Jan 2013; status: terminated.

02

Drugs

botulinum toxin type A
03

Conditions

equinus contracture

Beyond the preview

Go deeper on NCT02051933.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02051933.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call